Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacologic interaction between ifosfamide and aprepitant in soft tissue sarcoma
2017-004814-24Phase 4Completed
- Sponsor
- Institut Claudius Regaud
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aprepitant in soft tissue sarcoma (STS), sponsored by Institut Claudius Regaud. Started Jan 2018; status: completed.
02
Drugs
aprepitant
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2017-004814-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004814-24.